Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Completed · Phase 2

Conditions studied: Carcinoma of Unknown Primary, Pain

In brief

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well gemcitabine works in treating patients with metastatic cancer of unknown primary.

Key facts

Study ID
NCT00357630
Run by
Eastern Cooperative Oncology Group
People needed
52
Starts
2006-06-01
Last updated by the study team
2020-11-02

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.